Wikidata

(Q81595557)

English

A study from the EORTC new drug development group: open label phase II study of sabarubicin (MEN-10755) in patients with progressive hormone refractory prostate cancer

scientific article published on 07 December 2005

In more languages

Statements

title
A study from the EORTC new drug development group: open label phase II study of sabarubicin (MEN-10755) in patients with progressive hormone refractory prostate cancer (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16337787
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16337787%20AND%20SRC:MED&resulttype=core&format=json
retrieved
10 January 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q81595557&oldid=1947853569"